GLEEVEC vs IBTROZI

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 23, 2026·How we rate

Possible drug interaction. GLEEVEC and IBTROZI are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	GLEEVEC	IBTROZI
Rating	70/100	New
Pharmacy pays	~$25.80 /30	—
Type	RX	RX
Active ingredient	IMATINIB MESYLATE	TALETRECTINIB ADIPATE
Manufacturer	Novartis	Nuvation
Dosage forms	Tablet	Capsule
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	None
Treats	Lymphoid Leukemia, Myeloid Leukemia, Hypereosinophilic Syndrome	Non-Small-Cell Lung Carcinoma

gleevec ibtrozi

Rating

70/100

New

Pharmacy pays

~$25.80 /30

—

Type

Active ingredient

IMATINIB MESYLATE

TALETRECTINIB ADIPATE

Manufacturer

Novartis

Nuvation

Dosage forms

Tablet

Capsule

Drug class

Kinase Inhibitor

Boxed warning

None

Treats

Lymphoid Leukemia, Myeloid Leukemia, Hypereosinophilic Syndrome

Non-Small-Cell Lung Carcinoma

Frequently asked questions

What is the difference between Gleevec and Ibtrozi?

Gleevec contains Imatinib Mesylate, while Ibtrozi contains Taletrectinib Adipate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.